<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Direxion Daily Meta Bear 1x Shares — News on 6ix</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares</link>
<description>Latest news and press releases for Direxion Daily Meta Bear 1x Shares on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 02 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/direxion-daily-meta-bear-1x-shares" rel="self" type="application/rss+xml" />
<item>
<title>Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/worksport-announces-cortm-portable-energy-system-is-now-fully-certified-including-key-ul-and-csa-approvals-for-north-american-retail-and-commercial-distribution-29</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/worksport-announces-cortm-portable-energy-system-is-now-fully-certified-including-key-ul-and-csa-approvals-for-north-american-retail-and-commercial-distribution-29</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Final safety and compliance approvals complete; certification package supports broader sales across retail, fleet, distributor, and commercial channels WEST</description>
</item>
<item>
<title>Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/abeona-therapeuticsr-announces-new-qualified-treatment-center-for-zevaskynr-in-new-york-12</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/abeona-therapeuticsr-announces-new-qualified-treatment-center-for-zevaskynr-in-new-york-12</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>CLEVELAND, April 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of NewYork-Presbyterian/Columbia University</description>
</item>
<item>
<title>Advisory: Chevron Corporation’s 1Q 2026 Earnings Conference Call and Webcast</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/advisory-chevron-corporations-1q-2026-earnings-conference-call-and-webcast-3</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/advisory-chevron-corporations-1q-2026-earnings-conference-call-and-webcast-3</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>HOUSTON--(BUSINESS WIRE)-- Chevron Corporation (NYSE: CVX), one of the world's leading energy companies, will hold its quarterly earnings conference call on</description>
</item>
<item>
<title>Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies-14</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies-14</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>April 2, 2026 Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies Biodexa Pharmaceuticals PLC (Nasdaq: BDRX)</description>
</item>
<item>
<title>ZenaTech Initiates New Operations in Ukraine to Accelerate Production of Counter-UAS Interceptor Systems</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/zenatech-initiates-new-operations-in-ukraine-to-accelerate-production-of-counter-uas-interceptor-systems-15</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/zenatech-initiates-new-operations-in-ukraine-to-accelerate-production-of-counter-uas-interceptor-systems-15</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Ukraine operations will be structured for full regulatory compliance to support U.S. defense and Gulf nation adoption VANCOUVER, British Columbia, April 02,</description>
</item>
<item>
<title>Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/dexcom-schedules-first-quarter-2026-earnings-release-and-conference-call-for-april-30-2026-at-430-pm-eastern-time-4</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/dexcom-schedules-first-quarter-2026-earnings-release-and-conference-call-for-april-30-2026-at-430-pm-eastern-time-4</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close</description>
</item>
<item>
<title>Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/dermata-receives-notice-of-acceptance-of-australian-patent-application-for-topical-application-of-dermal-fillers-with-its-bioneedle-delivery-system-34</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/dermata-receives-notice-of-acceptance-of-australian-patent-application-for-topical-application-of-dermal-fillers-with-its-bioneedle-delivery-system-34</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>- This would be Dermata's first patent, if issued, covering the use of its Bioneedle Delivery System ("BDS") with dermal fillers -- The Company also has</description>
</item>
<item>
<title>Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/caris-life-sciences-announces-launch-of-caris-chromoseq-the-worlds-first-whole-genome-and-whole-transcriptome-tumor-profiling-assay-for-myeloid-malignancies</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/caris-life-sciences-announces-launch-of-caris-chromoseq-the-worlds-first-whole-genome-and-whole-transcriptome-tumor-profiling-assay-for-myeloid-malignancies</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Ultra-deep Whole Genome and Transcriptome Sequencing provides a more complete workup for myeloid malignancies with clearer, faster diagnostic insightIRVING,</description>
</item>
<item>
<title>Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/quantum-biopharma-wins-significant-court-challenge-in-usd-dollar700000000-claim-as-defendants-joint-motion-to-dismiss-lawsuit-alleging-market-manipulation-by-cibc-world-markets-and-rbc-dominion-securities-is-denied-8</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/quantum-biopharma-wins-significant-court-challenge-in-usd-dollar700000000-claim-as-defendants-joint-motion-to-dismiss-lawsuit-alleging-market-manipulation-by-cibc-world-markets-and-rbc-dominion-securities-is-denied-8</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a</description>
</item>
<item>
<title>LiveRamp Unlocks Identity-Driven Marketing with Unity to Power Better Returns in Gaming</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/liveramp-unlocks-identity-driven-marketing-with-unity-to-power-better-returns-in-gaming-2</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/liveramp-unlocks-identity-driven-marketing-with-unity-to-power-better-returns-in-gaming-2</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>SAN FRANCISCO--(BUSINESS WIRE)-- LiveRamp (NYSE: RAMP), the leader in data collaboration, today announced an expanded partnership with Unity (NYSE: U), the</description>
</item>
<item>
<title>CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of 2026</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/csw-industrials-increases-quarterly-dividend-by-11percent-to-dollar030-per-share-and-repurchases-dollar35m-in-shares-during-the-fiscal-fourth-quarter-of-2026-18</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/csw-industrials-increases-quarterly-dividend-by-11percent-to-dollar030-per-share-and-repurchases-dollar35m-in-shares-during-the-fiscal-fourth-quarter-of-2026-18</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>DALLAS, April 02, 2026 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NYSE: CSW) announced today that its Board of Directors has declared a regular quarterly cash</description>
</item>
<item>
<title>InterDigital signs license agreement with Buffalo Americas; adds new DTV agreements</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/interdigital-signs-license-agreement-with-buffalo-americas-adds-new-dtv-agreements-11</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/interdigital-signs-license-agreement-with-buffalo-americas-adds-new-dtv-agreements-11</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>WILMINGTON, Del., April 02, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a wireless, video, and AI technology research and development company,</description>
</item>
<item>
<title>LandBridge Announces Agreement with PowerBridge for the Development of a 2 GW Powered Data Center Campus</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/landbridge-announces-agreement-with-powerbridge-for-the-development-of-a-2-gw-powered-data-center-campus-3</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/landbridge-announces-agreement-with-powerbridge-for-the-development-of-a-2-gw-powered-data-center-campus-3</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Agreement provides option to lease acreage for the development of a 2 GW powered data center campus in West Texas on LandBridge acreage in close proximity to</description>
</item>
<item>
<title>Dalrada Technology Group, Inc. Announces Agreement Supporting Ultra-High Temperature Industrial Heat Pump Development</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/dalrada-technology-group-inc-announces-agreement-supporting-ultra-high-temperature-industrial-heat-pump-development-20</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/dalrada-technology-group-inc-announces-agreement-supporting-ultra-high-temperature-industrial-heat-pump-development-20</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>ESCONDIDO, CA / ACCESS Newswire / April 2, 2026 / Dalrada Technology Group, Inc. (the "Company" or "Dalrada") (OTCID:DHTI), a leader in advanced climate</description>
</item>
<item>
<title>Rivian Releases Q1 2026 Production and Delivery Figures and Sets Date for First Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/rivian-releases-q1-2026-production-and-delivery-figures-and-sets-date-for-first-quarter-2026-financial-results-4</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/rivian-releases-q1-2026-production-and-delivery-figures-and-sets-date-for-first-quarter-2026-financial-results-4</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>IRVINE, Calif.--(BUSINESS WIRE)-- Rivian Automotive, Inc. (NASDAQ: RIVN) today announced production and delivery totals for the quarter ending March 31,</description>
</item>
<item>
<title>Plato Gold Corp. Announces Sale of Timmins-Area Properties to Mayfair Gold Corp.</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/plato-gold-corp-announces-sale-of-timmins-area-properties-to-mayfair-gold-corp-8</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/plato-gold-corp-announces-sale-of-timmins-area-properties-to-mayfair-gold-corp-8</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>TORONTO, Ontario, April 02, 2026 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”)</description>
</item>
<item>
<title>ATI Announces Webcast for First Quarter 2026 Results</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/ati-announces-webcast-for-first-quarter-2026-results</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/ati-announces-webcast-for-first-quarter-2026-results</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>DALLAS, April 2, 2026 /PRNewswire/ -- ATI (NYSE: ATI) has scheduled the live webcast for its first quarter 2026 earnings conference call on Thursday, April</description>
</item>
<item>
<title>SM ENERGY ANNOUNCES EXPIRATION AND FINAL TENDER RESULTS OF PREVIOUSLY ANNOUNCED CASH TENDER OFFER</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/sm-energy-announces-expiration-and-final-tender-results-of-previously-announced-cash-tender-offer</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/sm-energy-announces-expiration-and-final-tender-results-of-previously-announced-cash-tender-offer</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>DENVER, April 2, 2026 /PRNewswire/ -- SM Energy Company ("SM Energy") (NYSE: SM) today announced the final tender results of the previously announced cash</description>
</item>
<item>
<title>Forward Air Named to Newsweek’s List of Most Trustworthy Companies in America 2026</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/forward-air-named-to-newsweeks-list-of-most-trustworthy-companies-in-america-2026-4</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/forward-air-named-to-newsweeks-list-of-most-trustworthy-companies-in-america-2026-4</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>DALLAS--(BUSINESS WIRE)-- Forward Air Corporation (NASDAQ: FWRD) (“Forward” or the “Company”) today announced it has been named to Newsweek’s list of the</description>
</item>
<item>
<title>Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)</title>
<link>https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/ultragenyx-announces-us-fda-acceptance-of-bla-resubmission-for-ux111-aav-gene-therapy-to-treat-sanfilippo-syndrome-type-a-mps-iiia-16</link>
<guid isPermaLink="true">https://6ix.com/company/direxion-daily-meta-bear-1x-shares/news/ultragenyx-announces-us-fda-acceptance-of-bla-resubmission-for-ux111-aav-gene-therapy-to-treat-sanfilippo-syndrome-type-a-mps-iiia-16</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>If approved, UX111 will be the first approved therapy for the treatment of Sanfilippo syndrome Type A, a rare disease affecting young children that leads to</description>
</item>
</channel>
</rss>